Skip to main content

Table 2 The patients accepted postoperative adjuvant therapy in this study

From: Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study

No.

Whether relapse

DFS (mouths)

Treatment

Ki67 index (%)

1

No recurred

18

Octreotide

5

2

Recurred

22

Octreotide

5

3

Recurred

17

Octreotide

15

4

Recurred

9

Chemotherapy (gemcitabine)

5

5

Recurred

13

Octreotide

4

6

Recurred

72

Chemotherapy (gemcitabine)

3